Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.3350 (7.43%) ($4.3350 - $4.3750) on Thu. Sep. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.68% (three month average) | RSI | 26 | Latest Price | $4.3350(7.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1% a day on average for past five trading days. | Weekly Trend | ATRA declines -10.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XAR(94%) IWF(93%) VUG(90%) INDA(87%) XBI(87%) | Factors Impacting ATRA price | ATRA will decline at least -5.34% in a week (0% probabilities). UUP(-30%) USO(-6%) VCSH(19%) VCIT(21%) OIH(21%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.34% (StdDev 10.68%) | Hourly BBV | 1.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $4.46 | 5 Day Moving Average | $4.09(5.99%) | 10 Day Moving Average | $4.24(2.24%) | 20 Day Moving Average | $4.46(-2.8%) | To recent high | -50.6% | To recent low | 51.8% | Market Cap | $322m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |